GPs have been advised to review patients taking rosiglitazone (Avandia) after changes to the product information of the type 2 diabetes drug and the loss of two indications. | more

Doctors at SA’s public hospitals will soon earn up to $140,000 more than their counterparts in other parts of Australia. | more

Retinopathy is a significant marker for coronary heart disease, regardless of whether the patient has diabetes, landmark research shows. | more

Initial refugee health assessments should be conducted by specialist services, not GPs, a new report says. | more